Quantitative Analysis and Correlation of HBeAg, HBeAb, and HBV DNA in Chronic Hepatitis B Patients in Swat, Khyber Pakhtunkhwa
DOI:
https://doi.org/10.57125/FEM.2025.03.30.06Keywords:
mean value, HBV DNA, HBeAg, HBeAb, chronic hepatitis B, correlationAbstract
Aims: The research aims to determine quantitative values of HBeAg and HBeAb concentrations in chronic hepatitis B patients while assessing their relationship with serum hepatitis B DNA levels.
Place and Duration of Study: This study was conducted at Saidu Teaching Hospital, Swat. This study lasts for 6 months, from December 2023 to April 2024.
Methodology: This study comprised 100 patients with confirmed HBV DNA positive and a chronic hepatitis B. Exclusion criteria included those using antiviral medication, those with autoimmune or metabolic liver disorders, and those with co-infections (HCV, HIV, or HDV). HBeAg and HBeAb levels were assessed using CLIA, and HBV DNA was processed using qRT-PCR. Accuracy was ensured using internal quality control measures. To evaluate the correlations between HBV DNA, HBeAg, and HBeAb, data analysis was done using SPSS Version 17.0 and Pearson correlation. P-values less than 0.05 were regarded as statistically significant.
Results: The mean viral load of the 100 patients was 60,800 IU/mL, and all of them tested positive for HBV DNA. HBeAb was 8.75 IU/mL on average, while HBeAg was 12.82 IU/mL on average. HBV DNA and HBeAg were found to be 59% associated, HBV DNA and HBeAb to be 46%, and HBeAg and HBeAb to be 77%, according to the correlation study. Epidemiological insights into the distribution and correlation of HBV markers in chronic hepatitis B patients are provided by these findings.
Conclusion: This study concluded that not all chronic HBV patients have HBeAg and HBeAb levels, which are lower than those of HBV DNA. These findings offer valuable information on the serological trends of chronic hepatitis B, which might aid in comprehending how the illness develops.
References
Liang TJ. Hepatitis B: the virus and disease. Hepatology [Internet]. 2009;49(5 Suppl):S13-21. Available from: http://dx.doi.org/10.1002/hep.22881
Veracruz N, Gish RG, Cheung R, Chitnis AS, Wong RJ. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019. J Viral Hepat [Internet]. 2022;29(5):352–65. Available from: http://dx.doi.org/10.1111/jvh.13663
Terrault NA, Lok ASF, McMahon BJ, Chang K-M, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology [Internet]. 2018;67(4):1560–99. Available from: http://dx.doi.org/10.1002/hep.29800
Idilman R. The summarized of EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Turk J Gastroenterol [Internet]. 2017;28(5):412–6. Available from: http://dx.doi.org/10.5152/tjg.2017.20817
Gergely A, Bechet S, Goujon C, Benabdelmoumen G, Consigny P-H. Hepatitis B screening in travelers: a retrospective analysis. Travel Med Infect Dis [Internet]. 2014;12(6 Pt B):707–12. Available from: http://dx.doi.org/10.1016/j.tmaid.2014.07.003
Di Bisceglie AM. Hepatitis B and hepatocellular carcinoma. Hepatology [Internet]. 2009;49(5 Suppl):S56-60. Available from: http://dx.doi.org/10.1002/hep.22962
Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol [Internet]. 2005;34 Suppl 1:S1-3. Available from: http://dx.doi.org/10.1016/s1386-6532(05)00384-7
Locarnini S, Littlejohn M, Aziz MN, Yuen L. Possible origins and evolution of the hepatitis B virus (HBV). Semin Cancer Biol [Internet]. 2013;23(6 Pt B):561–75. Available from: http://dx.doi.org/10.1016/j.semcancer.2013.08.006
Lee WM. Hepatitis B virus infection. N Engl J Med [Internet]. 1997;337(24):1733–45. Available from: http://dx.doi.org/10.1056/NEJM199712113372406
Khalil SA, Abdulkareem WL, Hussein NR. The effectiveness of post-exposure prophylaxis in infants born to hepatitis B virus positive mothers in the Kurdistan region, Iraq. Int J Infect [Internet]. 2016;5(2). Available from: http://dx.doi.org/10.5812/iji.42412
Borgia G, Carleo MA, Gaeta GB, Gentile I. Hepatitis B in pregnancy. World J Gastroenterol [Internet]. 2012;18(34):4677–83. Available from: http://dx.doi.org/10.3748/wjg.v18.i34.4677
Al-Sadeq DW, Taleb SA, Zaied RE, Fahad SM, Smatti MK, Rizeq BR, et al. Hepatitis B virus molecular epidemiology, host-virus interaction, coinfection, and laboratory diagnosis in the MENA region: An update. Pathogens [Internet]. 2019;8(2):63. Available from: http://dx.doi.org/10.3390/pathogens8020063
Alshayea AI, Eid GE, El-Hazmi MM, Alhetheel AF. Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia. Saudi Med J [Internet]. 2016;37(10):1114–9. Available from: http://dx.doi.org/10.15537/smj.2016.10.14705
Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc [Internet]. 2007;82(8):967–75. Available from: http://dx.doi.org/10.4065/82.8.967
Burns GS, Thompson AJ. Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harb Perspect Med [Internet]. 2014;4(12):a024935. Available from: http://dx.doi.org/10.1101/cshperspect.a024935
Lau GKK, Leung Y-H, Fong DYT, Au W-Y, Kwong Y-L, Lie A, et al. High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. Blood [Internet]. 2002;99(7):2324–30. Available from: http://dx.doi.org/10.1182/blood.v99.7.2324
Laras A, Papatheodoridi M, Panopoulou E, Papatheodoridis GV, Hadziyannis SJ, Hadziyannis E. Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B. Virol J [Internet]. 2022;19(1):22. Available from: http://dx.doi.org/10.1186/s12985-022-01749-7
Liaw Y-F. HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B. Hepatol Int [Internet]. 2009;3(3):425–33. Available from: http://dx.doi.org/10.1007/s12072-009-9140-3
Santantonio T, Mazzola M, Iacovazzi T, Miglietta A, Guastadisegni A, Pastore G. Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine. J Hepatol [Internet]. 2000;32(2):300–6. Available from: http://dx.doi.org/10.1016/s0168-8278(00)80076-8
Theise ND. Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol [Internet]. 2007;20 Suppl 1(S1):S3-14. Available from: http://dx.doi.org/10.1038/modpathol.3800693
Rasool G, Riaz M, Abbas M, Fatima H, Qamar MM, Zafar F, et al. COVID-19: Clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: A review. Int J Immunopathol Pharmacol [Internet]. 2022;36:3946320221115316. Available from: http://dx.doi.org/10.1177/03946320221115316
Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res [Internet]. 2021;149:1–61. Available from: http://dx.doi.org/10.1016/bs.acr.2020.10.001
Yuen M-F, Ng IO-L, Fan S-T, Yuan H-J, Wong DK-H, Yuen JC-H, et al. Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B. Am J Gastroenterol [Internet]. 2004;99(10):2032–7. Available from: http://dx.doi.org/10.1111/j.1572-0241.2004.40440.x
Li X, Zhao J, Yuan Q, Xia N. Detection of HBV covalently closed circular DNA. Viruses [Internet]. 2017;9(6). Available from: http://dx.doi.org/10.3390/v9060139
Ganji A, Esmaeilzadeh A, Ghafarzadegan K, Helalat H, Rafatpanah H, Mokhtarifar A. Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV. Hepat Mon. 2011;11(5):342–5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
